Karsten Denner

Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer

Ulrich Lücking, Arne Scholz, Philip Lienau et al. · ChemMedChem · 2017 · 184 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Site-selective Dephosphorylation of the Platelet-derived Growth Factor β-Receptor by the Receptor-like Protein-tyrosine Phosphatase DEP-1

Marina Kovalenko, Karsten Denner, Jill Sandström et al. · Journal of Biological Chemistry · 2000 · 150 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

Christian Zurth, Mikko Koskinen, Robert E. Fricke et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2019 · 102 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro

Anne Christiansen, Thomas Backensfeld, Karsten Denner et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2011 · 89 citations

Pharmacy, Pharmacokinetics, Toxicology +14

Cloning of CYP11B1 and CYP11B2 from normal human adrenal and their functional expression in COS-7 and V79 chinese hamster cells

Karsten Denner, Johannes Doehmer, Rita Bernhardt · Endocrine Research · 1995 · 76 citations

Life Sciences, Biochemistry, Molecular Biology +17